Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Fennell, Jérôme ^a   Vellinga, Akke ^b   Hanahoe, Belinda ^a   Morris, Dearbhaile ^b   Boyle, Fiona ^b   Higgins, Francis ^a   Lyons, Maura ^a   O'Connell, Karina ^a   Keady, Deirbhile ^a   Cormican, Martin ^a,b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; GENTAMICIN; MEROPENEM; NALIDIXIC ACID; NITROFURANTOIN; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD ANALYSIS; CAUSE OF DEATH; CHRONIC PATIENT; CONTROLLED STUDY; ESCHERICHIA COLI; ETHNIC GROUP; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFORMATION DISSEMINATION; IRELAND; IRISH; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PREVALENCE; RISK FACTOR; SCREENING TEST; TREND STUDY; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; IRELAND; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE;

EID: 84860893959     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-116     Document Type: Article

References (27)

1. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983, 11:315-317. 10.1007/BF01641355, 6321357.
2. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004, 48:4574-4581. 10.1128/AAC.48.12.4574-4581.2004, 529180, 15561828.
3. Paterson DL, Ko WC, von Gottenberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice L, McCormack JG, Yu VL. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001, 39:2206-2212. 10.1128/JCM.39.6.2206-2212.2001, 88112, 11376058.
4. Paterson DL, Ko WC, von Gottenberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA Rice LB, Wagener MM, McCormack JG, Yu VL. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 2004, 39:31-37. 10.1086/420816, 15206050.
5. Mangeney N, Niel P, Paul G, Faubert E, Hue S, Dupeyron C, Louarn F, Leluan G. A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J Appl Microbiol 2000, 88:504-511. 10.1046/j.1365-2672.2000.00989.x, 10747231.
6. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001, 32:1162-1171. 10.1086/319757, 11283805.
7. Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 2006, 27:1226-1232. 10.1086/507962, 17080381.
8. Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005, 56:451-454. 10.1093/jac/dki239, 16006451.
9. Arpin C, Dubois V, Coulange L, Andre C, Fischer I, Noury P, Grobost F, Brochet JP, Jullin J, Dutilh B, Couture JF, Noury P, Lagrange I, Ducastaing A, Doermann HP, Quentin C. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 2003, 47:3506-3514. 10.1128/AAC.47.11.3506-3514.2003, 253776, 14576109.
10. Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC, Jacoby GA. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990, 34:2193-2199. 10.1128/AAC.34.11.2193, 172022, 2073110.
11. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999, 281:517-523. 10.1001/jama.281.6.517, 10022107.
12. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004, 54:735-743. 10.1093/jac/dkh424, 15347638.
13. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008, 62(Suppl 2):ii41-54. ii41-ii54.
14. Grogan J, Murphy H, Butler K. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Dublin paediatric hospital. Br J Biomed Sci 1998, 55:111-117.
15. Health Protection Surveillance Centre Annual Report 2007 [http://www.hpsc.ie/hpsc/AboutHPSC/AnnualReports/File,3377,en.pdf].
16. NiChulain M, Murray AM, Corbett-Feeney G, Cormican M. Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 2005, 174:6-9. 10.1007/BF03168974, 16445153.
17. Morris D, Murphy A, Pickup M, Hanahoe B, Fenelon L, Cormican M. Recognition of Cefotaximase ProducingE. colias a Urinary Tract Pathogen in Ireland. EPI-Insight 2005, 6:3-4.
18. Pelly H, Morris D, O'Connell E, Hanahoe B, Chambers C, Biernacka K, Gray S, Cormican M. Outbreak of extended spectrum beta-lactamase producingE. coliin a nursing home in Ireland, May 2006. Euro Surveill 2006, 11:E060831.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Eighth Informational Supplement . CLSI document M100-S8.1998 Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania..
20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21 (ISBN 1-56238-742-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087 USA, 2011..
21. McMullan R, Loughrey AC, McCalmont M, Rooney PJ. Clinico-epidemiological features of infections caused by CTX-M type extended spectrum beta lactamase-producing Escherichia coli in hospitalised patients. J Infect 2007, 54:46-52. 10.1016/j.jinf.2006.01.004, 16483662.
22. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008, 52:2818-2824. 10.1128/AAC.00171-08, 2493136, 18505851.
23. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004, 42:1089-1094. 10.1128/JCM.42.3.1089-1094.2004, 356843, 15004058.
24. Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 1999, 37:4065-4070. 85882, 10565933.
25. O'Fallon E, Schreiber R, Kandel R, D'Agata EM. Multidrug-resistant gram-negative bacteria at a long-term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control Hosp Epidemiol 2009, 30:1172-1179. 10.1086/648453, 19835474.
26. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49:682-690. 10.1086/604713, 19622043.
27. Royal College of Physicians of Ireland. Policy Group on Healthcare-Associated Infection (HCAI) 2009, Antibiotic Use And The Implications For Healthcare-Associated Infection. Dublin, http://www.rcpi.ie/News/Documents/AntibioticUseandImplicationsforHCAI.pdf, Royal College of Physicians of Ireland. Policy Group on Healthcare-Associated Infection (HCAI).